Novocure’s $400 Million Multi-Tranche Non-Dilutive Debt Financing

Leila Ahmed North America Legal Chronicle
Tagged:

Fenwick & West represented Pharmakon Advisors in the transaction.Novocure (NASDAQ: NVCR) announced today that it has entered into a new five-year up to $400 million committed…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here